Form 8-K - Current report:
SEC Accession No. 0001213900-25-108192
Filing Date
2025-11-10
Accepted
2025-11-10 16:00:46
Documents
15
Period of Report
2025-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0264778-8k_bluejay.htm   iXBRL 8-K 25477
2 PRESS RELEASE, DATED NOVEMBER 10, 2025 ea026477801ex99-1_bluejay.htm EX-99.1 14983
3 GRAPHIC image_001.jpg GRAPHIC 14567
4 GRAPHIC ex99-1_001.jpg GRAPHIC 6355
  Complete submission text file 0001213900-25-108192.txt   256610

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bjdx-20251110.xsd EX-101.SCH 3017
6 XBRL LABEL FILE bjdx-20251110_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE bjdx-20251110_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0264778-8k_bluejay_htm.xml XML 3474
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720 (978) 631-0152
Bluejay Diagnostics, Inc. (Filer) CIK: 0001704287 (see all company filings)

EIN.: 473552922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41031 | Film No.: 251466001
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)